1. Academic Validation
  2. [Peptide TAT modified polyethylenimine-beta-cyclodextrin for gene delivery]

[Peptide TAT modified polyethylenimine-beta-cyclodextrin for gene delivery]

  • Zhejiang Da Xue Xue Bao Yi Xue Ban. 2009 Jan;38(1):15-23. doi: 10.3785/j.issn.1008-9292.2009.01.003.
Li-Hua Lai 1 Qi-Ying Jiang Dan Chen Yi-Ping Hu Hai Yu Qing-Qing Wang Gu-Ping Tang
Affiliations

Affiliation

  • 1 Institute of Immunology, College of Medicine, Zhejiang University, Hangzhou 310058, China.
Abstract

Objective: To develop a novel gene delivery vector TAT-PEI-beta-CyD.

Methods: beta-cyclodextrin (beta-CyD) was linked by low molecular weight (PEI 600) via 1, 1-carbonyldiimidazole (CDI), and TAT peptide (RRRQRRKKRC) was coupled to PEI 600 by [N-succinimidy-3-(2-pyridyldithio) propionate, SPDP]. The copolymer was characterized by (1)H-NMR and FT-IR. Physiochemical characteristics of TAT-PEI-beta-CyD/DNA complexes were tested by Agarose gel electrophoresis and particle size measurements. Cell viability and transfection efficiency were evaluated in A293 and B16 cells using PEI 25 kDa as a control.

Result: TAT peptide was successfully coupled to PEI-beta-CyD. The result of gel electrophoresis showed that the TAT-PEI-beta-CyD was able to condense DNA efficiently at N/P ratio of 4. The particle size of TAT-PEI-beta-CyD/DNA complexes was around 100 nm. The cytotoxicity of TAT-PEI-beta-CyD was lower than that of PEI 25 kDa. The transfection efficiency of TAT-PEI-beta-CyD was higher than that of PEI 25 kDa in A293 and B16 cells at N/P ratio of 30.

Conclusion: The novel vector TAT-PEI-beta-CyD has been developed successfully with low cytotoxicity and high transfection efficiency.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-P5283
    Peptide